146 related articles for article (PubMed ID: 1717129)
21. Adjuvant intraarterial injection of 131I-labeled lipiodol after resection of hepatocellular carcinoma: progress report of a case-control study with a 5-year minimal follow-up.
Boucher E; Bouguen G; Garin E; Guillygomarch A; Boudjema K; Raoul JL
J Nucl Med; 2008 Mar; 49(3):362-6. PubMed ID: 18287267
[TBL] [Abstract][Full Text] [Related]
22. Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma.
Raoul JL; Guyader D; Bretagne JF; Heautot JF; Duvauferrier R; Bourguet P; Bekhechi D; Deugnier YM; Gosselin M
Hepatology; 1997 Nov; 26(5):1156-61. PubMed ID: 9362356
[TBL] [Abstract][Full Text] [Related]
23. Preoperative treatment of hepatocellular carcinoma with intra-arterial injection of 131I-labelled lipiodol (Br J Surg 2003; 90: 1379-1383).
Rai R; Rai S
Br J Surg; 2004 Mar; 91(3):373; author reply 373. PubMed ID: 14991642
[No Abstract] [Full Text] [Related]
24. Superselective intra-arterial radiometabolic therapy with I-131 lipiodol in hepatocellular carcinoma.
Maini CL; Scelsa MG; Fiumara C; Tofani A; Sciuto R; Tipaldi L; D'Annibale M; Santoro E
Clin Nucl Med; 1996 Mar; 21(3):221-6. PubMed ID: 8846568
[TBL] [Abstract][Full Text] [Related]
25. Intra-arterial injection of iodine-131-labeled lipiodol for treatment of hepatocellular carcinoma.
Boucher E; Garin E; Guylligomarc'h A; OliviƩ D; Boudjema K; Raoul JL
Radiother Oncol; 2007 Jan; 82(1):76-82. PubMed ID: 17141900
[TBL] [Abstract][Full Text] [Related]
26. Radioiodinated fatty acid esters in the management of hepatocellular carcinoma: preliminary findings.
Yoo HS; Park CH; Suh JH; Lee JT; Kim DI; Kim BS; Madsen MT
Cancer Chemother Pharmacol; 1989; 23 Suppl():S54-8. PubMed ID: 2538267
[TBL] [Abstract][Full Text] [Related]
27. Report of a pilot study of intra-arterial injection of I-131 lipiodol for the treatment of hepatoma.
Lui WY; Liu RS; Chiang JH; Lo JG; Lai KH; King KL; Cheng HC; Wei YY; Chi CW; P'eng FK
Zhonghua Yi Xue Za Zhi (Taipei); 1990 Sep; 46(3):125-33. PubMed ID: 2178041
[TBL] [Abstract][Full Text] [Related]
28. [Possibility of radiotherapy of hepatic cancer by transcatheter arterial embolization with radioactive Lipiodol].
Kobayashi H; Nakajo M; Shimabukuro K; Shirono K; Sakata H; Oyama T; Sonoda T; Shinohara S
Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Jan; 44(1):96-8. PubMed ID: 6330667
[No Abstract] [Full Text] [Related]
29. 131-iodine Lipiodol therapy in hepatocellular carcinoma.
Raoul JL; Boucher E; Roland V; Garin E
Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):348-55. PubMed ID: 19521315
[TBL] [Abstract][Full Text] [Related]
30. Hepatic intraarterial 131I iodized oil for treatment of hepatocellular carcinoma in patients with impeded portal venous flow.
de Baere T; Taourel P; Tubiana JM; Kuoch V; Ducreux M; Lumbroso J; Roche AJ
Radiology; 1999 Sep; 212(3):665-8. PubMed ID: 10478229
[TBL] [Abstract][Full Text] [Related]
31. Limitations of hyperselective intraarterial injections for the treatment of hepatocellular carcinoma.
Raoul JL; Bretagne JF; Bourguet P; Duvauferrier R
Invest Radiol; 1996 May; 31(5):305-7. PubMed ID: 8724131
[TBL] [Abstract][Full Text] [Related]
32. Hepatocellular carcinoma and adjuvant intra-arterial [131I]Lipiodol.
Launois B; Maddern G
Br J Surg; 2002 Nov; 89(11):1345-6. PubMed ID: 12390371
[No Abstract] [Full Text] [Related]
33. Intraarterial injection therapy of newly developed cisplatin-phosphatidyl choline-lipiodol suspension for hepatocellular carcinoma.
Isomoto I; Aikawa H; Mori H; Matsunaga N; Ajimu A; Fukuda T; Ogasawara M
Radiat Med; 1992; 10(1):19-25. PubMed ID: 1374923
[TBL] [Abstract][Full Text] [Related]
34. Selective radionuclide localisation in primary liver tumours (pilot study).
Novell JR; Green AJ; Hilson AJ; Dusheiko G; Dick R; Hobbs KE
HPB Surg; 1994; 7(3):185-99; discussion 200. PubMed ID: 8155585
[TBL] [Abstract][Full Text] [Related]
35. Biologic dosimetry of 188Re-HDD/lipiodol versus 131I-lipiodol therapy in patients with hepatocellular carcinoma.
De Ruyck K; Lambert B; Bacher K; Gemmel F; De Vos F; Vral A; de Ridder L; Dierckx RA; Thierens H
J Nucl Med; 2004 Apr; 45(4):612-8. PubMed ID: 15073257
[TBL] [Abstract][Full Text] [Related]
36. 131I lipiodol therapy for unresectable hepatocellular carcinoma.
Rindani RB; Hugh TJ; Roche J; Roach PJ; Smith RC
ANZ J Surg; 2002 Mar; 72(3):210-4. PubMed ID: 12071454
[TBL] [Abstract][Full Text] [Related]
37. Transcatheter internal radiotherapy of hepatoma using radioactive iodized oil (I-131 Lipiodol).
Kobayashi H; Nakajo M; Yano T; Shimabukuro K; Shinohara S
Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Aug; 45(8):1176-8. PubMed ID: 3005962
[No Abstract] [Full Text] [Related]
38. Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres.
Lau WY; Ho S; Leung TW; Chan M; Ho R; Johnson PJ; Li AK
Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):583-92. PubMed ID: 9486608
[TBL] [Abstract][Full Text] [Related]
39. Inoperable hepatocellular carcinoma: transarterial 188Re HDD-labeled iodized oil for treatment--prospective multicenter clinical trial.
Kumar A; Srivastava DN; Chau TT; Long HD; Bal C; Chandra P; Chien le T; Hoa NV; Thulkar S; Sharma S; Tam le H; Xuan TQ; Canh NX; Pant GS; Bandopadhyaya GP
Radiology; 2007 May; 243(2):509-19. PubMed ID: 17456873
[TBL] [Abstract][Full Text] [Related]
40. Treatment of unresectable hepatocellular carcinoma with radiolabelled lipiodol.
Kanhere HA; Leopardi LN; Fischer L; Kitchener MI; Maddern GJ
ANZ J Surg; 2008 May; 78(5):371-6. PubMed ID: 18380736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]